Literature DB >> 803937

The onset of immune protection in acute experimental Chagas' disease in C3H(HE) mice.

R E Kuhn, S K Durum.   

Abstract

Entities:  

Mesh:

Year:  1975        PMID: 803937     DOI: 10.1016/0020-7519(75)90113-7

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


× No keyword cloud information.
  8 in total

Review 1.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells.

Authors:  S G Reed
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  Immune T cells control Trypanosoma cruzi infections.

Authors:  A C Corsini; A Stelini
Journal:  Experientia       Date:  1981

4.  Cellular immunity in chronic Chagas' disease.

Authors:  O M Montufar; C C Musatti; E Mendes; N F Mendes
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

5.  Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages.

Authors:  D E Burgess; W L Hanson
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

6.  Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection.

Authors:  F Kierszenbaum; M M Pienkowski
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Mechanisms of resistance against experimental Trypanosoma cruzi infection. Requirements for cellular destruction of circulating forms of T. cruzi in human and murine in vitro systems.

Authors:  F Kierszenbaum; M M Hayes
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

8.  Trypanosoma cruzi: modification of macrophage function during infection.

Authors:  N Nogueira; S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.